Lilly Forteo Labeling Talks Last Step Before Approval; GMP Issues Resolved
Executive Summary
Lilly completion of Forteo labeling negotiations with FDA is the only remaining hurdle before final approval, following the resolution of manufacturing issues for the osteoporosis agent